UK Medical Device Company Announces Two New Patents Granted by the US Patent and Trademark Officeby iData Research February 9, 2017
Register to receive a free European Market for Dental Bone Graft Substitutes, Barrier Membranes and Other Biomaterials report synopsis and brochure
SIRAKOSS Ltd., a UK-based medical device company developing bone grafting solutions, has recently announced that the United States Patent and Trademark Office (USPTO) has granted two patents for its bone graft technologies. SIRAKOSS’ patent portfolio encompasses advanced synthetic bone graft technologies which form the company’s product pipeline designed to address the significant clinical need for a fully-synthetic, standalone bone void filler. SIRAKOSS’ technologies provide consistently effective bone regeneration without the established risks found by using either autograft or therapeutics-based products such as BMP’s.
The two new granted patents are important additions to SIRAKOSS’ intellectual property estate and significantly enhance the company’s technology and product pipeline. Patent US 9,492,591 describes novel formulations of putty products, where the SIRAKOSS core technology may be combined with modified resorbable polymer carriers to produce a bone graft with improved handling characteristics and enhanced efficacy. The second patent (US 9,492,585) describes a range of bone graft technologies with specific microstructural properties that expands the potential products that SIRAKOSS can develop. These two new patents add to SIRAKOSS’ robust existing granted patents in Europe, Japan, Australia and China, and to the company’s core IP estate in the USA, Japan and Australia.
These patent grants occur as SIRAKOSS is advancing the development of its lead technology in Europe toward market.
The company’s proprietary technology is entirely synthetic, containing no human tissue and can be manufactured in consistent, high quality batches. Surgeon feedback on pre-clinical performance data and handling properties of the SIRAKOSS bone graft substitutes, when compared to currently available products, has been very encouraging. The alternative approach against which all other options are measured is autograft – the ‘gold standard’ – where healthy bone is harvested from the patient’s hip and replanted at the defect site. The amount of bone that is available for grafting is limited, particularly in children, and requires two invasive operative procedures, increasing the risk for the patient and the cost for the hospital. Other alternatives have seen products derived from cadaver bone, but these can be inconsistent in their performance.
Brian Butchart, CEO of SIRAKOSS, said “The granting of these two patents endorses the breadth of our technology and provides SIRAKOSS further protection for its unique product offerings in the largest single market for bone graft substitutes.”
Investor director, Sinclair Dunlop, Managing Partner at Epidarex Capital, said “this welcome expansion of SIRAKOSS’ global IP estate furthers the competitiveness of the company’s core technology and its potential for meeting a large market, driven by patient needs”
Synthetic bone grafts are used in trauma, spinal and dental surgery to fuse bones together to correct congenital or degenerative conditions (such as curvature of the spine) or following a traumatic injury where the bone fails to heal.
For Further Information
More on the dental biomaterials market in Europe can be found in the report series published by iData entitled European Market for Dental Bone Graft Substitutes, Barrier Membranes and Other Biomaterials. This report covers the European markets for dental bone graft substitutes, dental growth factors, and dental barrier membranes.
The iData series on the market for dental bone graft substitutes, barrier membranes and other biomaterials covers the U.S., Brazil, China, Japan, India, U.K., Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, and Switzerland. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at email@example.com for a European Market for Dental Bone Graft Substitutes, Barrier Membranes and Other Biomaterials report brochure and synopsis.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
About iPolicy Search
iPolicy Search allows medical device manufacturers and reimbursement consultants to drastically reduce their research time by searching an automatically updating database of policies from over 200 insurance groups in the United States.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to firstname.lastname@example.org with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.